MOUNTAIN VIEW, CA--(MARKET WIRE)--Oct 13, 2008 -- Hansen Medical, Inc. (HNSN - News), the global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced today that it will release its financial and operating results for the third quarter ended September 30, 2008 after market close on Thursday, October 23, 2008.

Hansen Medical will host a conference call at 5:00 p.m. EDT (2:00 p.m. PDT) on October 23, 2008 to discuss its results. The call may be accessed by dialing 877-326-9969 (303-205-0055 for international callers) and via the Internet in the Investor Relations section of Hansen Medical's website at www.hansenmedical.com. Please go to the website at least 15 minutes early to register, download and install any necessary audio software. Following the call, a webcast replay will be available on Hansen Medical's website, and an audio replay will also be available by calling 800-405-2236 (303-590-3000 for international callers) and entering the passcode 11121112. Both the audio and webcast replays will be available through October 30, 2008.

About Hansen Medical, Inc.

Hansen Medical, Inc., based in Mountain View, Calif., develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first product, the Sensei(TM) Robotic Catheter system, is a robotic navigation system that enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately and with stability during complex cardiac arrhythmia procedures. The Sensei system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data and was cleared by the U.S. Food and Drug Administration (FDA) in May 2007 for manipulation and control of certain mapping catheters in Electrophysiology (EP) procedures. The safety and effectiveness of the Sensei system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established. In the European Union, the Sensei system is cleared for use during EP procedures, such as guiding catheters in the treatment of AF. Additional information can be found at www.hansenmedical.com.

     Investor Contact:
     Steven Van Dick
     650.404.5800
     Email Contact
      
     Lasse Glassen
     Financial Relations Board
     213.486.6546
     Email Contact
      
     Media Contact:
     Amy Cook
     925.552.7893
     Email Contact